Tuoxin Pharmaceutical Group Co.,Ltd. (SHE:301089)

SHE:301089 Statistics

Total Valuation

SHE:301089 has a market cap or net worth of CNY 3.55 billion. The enterprise value is 3.31 billion.

Market Cap	3.55B
Enterprise Value	3.31B

Important Dates

The last earnings date was Saturday, March 28, 2026.

Earnings Date	Mar 28, 2026
Ex-Dividend Date	n/a

Share Statistics

SHE:301089 has 126.54 million shares outstanding. The number of shares has increased by 1.91% in one year.

Current Share Class	126.54M
Shares Outstanding	126.54M
Shares Change (YoY)	+1.91%
Shares Change (QoQ)	+11.87%
Owned by Insiders (%)	54.77%
Owned by Institutions (%)	1.10%
Float	57.05M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	9.39
PB Ratio	2.39
P/TBV Ratio	2.53
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 169.29, with an EV/FCF ratio of -46.87.

EV / Earnings	-47.53
EV / Sales	8.75
EV / EBITDA	169.29
EV / EBIT	n/a
EV / FCF	-46.87

Financial Position

The company has a current ratio of 4.01, with a Debt / Equity ratio of 0.00.

Current Ratio	4.01
Quick Ratio	2.55
Debt / Equity	0.00
Debt / EBITDA	0.17
Debt / FCF	-0.05
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -4.59% and return on invested capital (ROIC) is -3.79%.

Return on Equity (ROE)	-4.59%
Return on Assets (ROA)	-1.74%
Return on Invested Capital (ROIC)	-3.79%
Return on Capital Employed (ROCE)	-3.14%
Weighted Average Cost of Capital (WACC)	1.01%
Revenue Per Employee	243,935
Profits Per Employee	-44,914
Employee Count	1,551
Asset Turnover	0.22
Inventory Turnover	1.55

Taxes

Income Tax	-2.72M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +9.35% in the last 52 weeks. The beta is -0.59, so SHE:301089's price volatility has been lower than the market average.

Beta (5Y)	-0.59
52-Week Price Change	+9.35%
50-Day Moving Average	28.88
200-Day Moving Average	31.49
Relative Strength Index (RSI)	48.10
Average Volume (20 Days)	2,287,208

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, SHE:301089 had revenue of CNY 378.34 million and -69.66 million in losses. Loss per share was -0.55.

Revenue	378.34M
Gross Profit	99.80M
Operating Income	-47.65M
Pretax Income	-72.39M
Net Income	-69.66M
EBITDA	17.67M
EBIT	-47.65M
Loss Per Share	-0.55

Balance Sheet

The company has 245.41 million in cash and 3.25 million in debt, with a net cash position of 242.16 million or 1.91 per share.

Cash & Cash Equivalents	245.41M
Total Debt	3.25M
Net Cash	242.16M
Net Cash Per Share	1.91
Equity (Book Value)	1.48B
Book Value Per Share	11.45
Working Capital	438.98M

Cash Flow

In the last 12 months, operating cash flow was -26.19 million and capital expenditures -44.45 million, giving a free cash flow of -70.64 million.

Operating Cash Flow	-26.19M
Capital Expenditures	-44.45M
Depreciation & Amortization	65.31M
Net Borrowing	n/a
Free Cash Flow	-70.64M
FCF Per Share	-0.56

Margins

Gross margin is 26.38%, with operating and profit margins of -12.59% and -18.41%.

Gross Margin	26.38%
Operating Margin	-12.59%
Pretax Margin	-19.13%
Profit Margin	-18.41%
EBITDA Margin	4.67%
EBIT Margin	-12.59%
FCF Margin	n/a

Dividends & Yields

SHE:301089 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.91%
Shareholder Yield	-1.91%
Earnings Yield	-1.96%
FCF Yield	-1.99%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1